, and other resources referenced in each issue of In the Clinic. CME Objective: To review current evidence for the screening, diagnosis, treatment, and practice improvement of generalized anxiety disorder.
Which patients are at elevated risk for generalized anxiety disorder? GAD is twice as common in women as in men (6). Patients with comorbid psychiatric disorders (7, 8) , obesity (9), history of substance abuse (10), history of trauma (11, 12) , and family history of GAD (13) are also at increased risk for GAD. 6.1 (95% CI, (13) .
A meta-analysis of family and twin studies of common anxiety disorders showed a significant association between GAD in patients and their first-degree relatives, with an odds ratio of

Are preventive measures useful for patients at elevated risk?
Although prevention or early intervention may reduce the excess disability due to mental disorders, currently there is no evidence on the effectiveness of preventive measures for GAD in adults. However, in children who exhibit withdrawn behavior or early signs of anxiety, cognitive behavioral therapy (CBT) and parent education can prevent development of GAD (14, 15) , suggesting the possibility of benefit in adults as well.
Should clinicians screen patients for generalized anxiety disorder if they are at increased risk? If so, how?
Although there are no high-quality studies demonstrating a benefit to screening or to early treatment for GAD, the disorder is undertreated: 58% of persons diagnosed with GAD go untreated (16, 17) . As seen in depression care, better detection may be the first step in addressing underdiagnosis and undertreatment and in improving patient outcomes (18).
The screening tools to detect GAD vary in length and number of additional disorders included in the tool. Two brief and accurate options may be most feasible in primary care: the Generalized Anxiety Disorder-2 (GAD-2) (see the Box: Screening Questions for Generalized Anxiety Disorder) and the single-item screening question, "Are you bothered by nerves?" In the 2-item GAD-2 tool, the response to each question is given a score of 0, 1, 2, or 3 (for a total score of 0 to 6). A score of 3 or more has a sensitivity of 86% and specificity of 83% for detecting GAD in a primary care setting (19) . The single item screening question, "Are you bothered by nerves?" has 100% sensitivity and 59% specificity among average-risk primary care patients (20) . Alternatively, the Generalized Anxiety Disorder-7 (GAD-7) scale (21) and the Primary Care Evaluation of Mental Disorders (PRIME-MD) (22) are slightly longer screening tools that include additional questions to assess symptom severity and can thus be used to monitor symptoms. The 4-item Patient Health Questionnaire (PHQ-4) (23) provides an ultrabrief screen for both depression and anxiety. A nxiety can be an appropriate response to stressful situations but is considered a pathologic disorder when it is disabling and difficult to control. Generalized anxiety disorder (GAD) is the most common anxiety disorder seen in primary care, affecting approximately 3% of adults in the United States (1, 2). This disorder is characterized by at least 6 months of pervasive and excessive anxiety; recurring worry about common events; and physical symptoms, such as muscle tension, insomnia, and fatigue (3). The disorder is associated with reduced global life satisfaction, decreased work productivity, lower health-related quality of life (4), and greater health care use and medical costs (4, 5). Primary care physicians can effectively evaluate, diagnosis, and manage most patients with GAD.
Screening
Screening Questions for Generalized Anxiety Disorder: GAD-2 Screening Instrument
During the past month, have you been bothered a lot by: 
Diagnostic Criteria for Generalized Anxiety Disorder
Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months, about a number of events or activities (such as work or school performance). The individual finds it difficult to control the worry. The anxiety and worry are associated with 3 (or more) of the following 6 symptoms (with at least some symptoms having been present for more days than not for the past 6 months):
• Restless or feeling keyed up or on edge.
• Being easily fatigued.
• Difficulty concentrating or mind going blank.
• Irritability.
• Muscle tension.
• Sleep disturbances (difficulty falling or staying asleep, or restless, unsatisfying sleep). The anxiety, worry, or physical symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. The disturbance is not attributable to the physiologic effects of a substance (e.g., drug of abuse, medication) or another medical condition (e.g., hyperthyroidism). The disturbance is not better explained by another mental disorder (e.g., anxiety or worry about having panic attacks in panic disorder, negative evaluation in social anxiety disorder [social phobia], contamination or other obsessions in obsessive-compulsive disorder, separation from attachment figures in separation anxiety disorder, reminders of traumatic events in posttraumatic stress disorder, gaining weight in anorexia nervosa, physical problems in somatic symptoms disorder, body dysmorphic disorder, having a serious illness in illness anxiety disorder, or the content of delusional beliefs in schizophrenia or delusional disorder). Patients must meet all 6 criteria for a diagnosis of generalized anxiety disorder.
concentrating, irritability, muscle tension, or sleep disturbance. Patients must meet all 6 diagnostic criteria.
What physical examination findings indicate possible generalized anxiety disorder?
A patient with GAD can appear restless, irritable, or fatigued. In primary care settings, patients with GAD may also have medically unexplained symptoms, such as chest pain and rapid heart rate (18). A thorough physical What symptoms should prompt clinicians to consider a diagnosis of generalized anxiety disorder? GAD is characterized by excessive and difficult-to-control worries about everyday events and problems, resulting in distress or marked trouble in performing dayto-day tasks. According to the DSM-V (see the Box), the excessive anxiety and worry of GAD is associated with 3 or more of the following symptoms occurring on more days than not for at least 6 months: restlessness, difficulty SCREENING... Clinicians might consider screening for GAD among adults who are at increased risk. Multiple screening tools have similar sensitivity and specificity, so a busy clinician might be inclined to use a tool with as few as 1 or 2 questions. examination is necessary and may uncover an underlying or cooccurring medical condition that requires further evaluation (3).
CLINICAL
What laboratory tests should clinicians use?
No laboratory testing is necessary to diagnose GAD. However, clinicians should consider directed laboratory testing to exclude medical conditions suggested by the presenting symptoms as well as physical signs found during the evaluation (24). Among the most useful tests in patients presenting with symptoms of anxiety are thyroid function tests to exclude thyroid disease, hemoglobin measurement to exclude anemia, and a urine drug screen if substance use is a potential concern, but other routine laboratory testing has a low yield. In particular, catecholamine levels to check for pheochromocytoma should primarily be limited to persons with a family history of endocrine disorders or those with episodic hypertension, headaches, and palpitations.
What other diagnoses should clinicians consider?
Several physical and mental disorders can mimic or co-occur with GAD (Table 1 ). In fact, more than half of patients with GAD have comorbid mental illnesses (6). In evaluating patients for GAD, clinicians should consider medical conditions (e.g., cardiac, pulmonary, or endocrine illnesses); mood and other anxiety disorders, such as simple or social phobia, panic disorder, obsessive-compulsive disorder, acute stress disorder, and posttraumatic stress disorder; side effects of prescribed or over-the-counter medications and supplements; and substance misuse and withdrawal.
Patients with GAD may use alcohol and benzodiazepines to control anxiety, so clinicians should be vigilant to assess for substance misuse. If symptoms of anxiety persist after appropriate treatment of physical
Differential Diagnosis for Generalized Anxiety Disorder
Disease Notes
Cardiopulmonary disorders (such as asthma, These disorders can co-occur with generalized anxiety chronic obstructive pulmonary disease, disorder or mimic anxiety symptoms. Medications used to or congestive heart failure) treat these disorders, such as β-agonists, may also cause symptoms mimicking generalized anxiety disorder. Endocrine disease, including thyroid disorders, Many endocrine disorders (most commonly hyperthyroidism, diabetes, and hypoglycemia hypoglycemia, or hypothyroidism) can mimic anxiety symptoms. Consider thyroid function tests and blood glucose testing. Consider catecholamine level testing, limited to patients with a family history of endocrine neoplasms or those with episodic headaches, hypertension, and palpitations, for evaluation of pheochromocytoma. Mood disorders, including major depressive Generalized anxiety disorder and mood disorders frequently disorder and bipolar disorder co-occur. Symptoms of mood disorders should be treated first. As the depression is treated, symptoms of generalized anxiety disorder may become more apparent. Other anxiety disorders, including simple or Generalized anxiety disorder can be diagnosed in the social phobia, panic disorder, obsessivepresence of any other anxiety disorder if there is disabling, compulsive disorder, acute stress disorder, and generalized worry in addition to other symptoms. posttraumatic stress disorder Prescribed and over-the-counter medications Corticosteroids, sympathomimetics, and herbal medications (such as ginseng) may mimic symptoms of generalized anxiety disorder. Misuse of such substances as alcohol, benzoStimulant (nicotine, caffeine, amphetamines, cocaine, diazepines, caffeine, nicotine, amphetamine, and various "party pills") intoxication can cause anxiety cocaine, and other stimulants and mimic generalized anxiety disorder. Anxiety is also a symptom of alcohol and benzodiazepine withdrawal.
Consider ordering a drug screen and taking a detailed history if substance use is suspected. such as the selective serotonin reuptake inhibitors, are preferred as first-line drug therapy because they are as effective as benzodiazepines but lack the risk for dependency and cognitive impairment (31-39). In patients older than 60 years, a randomized, controlled trial suggested that sertraline may be superior to CBT for treating anxiety (40). Patient preference and potential side effects should guide decisions on drug therapy. Short-term treatment with alprazolam or diazepam can rapidly control anxiety symptoms during the period before the anxiolytic properties of an antidepressant take effect (41). Clinicians can consider prescribing a benzodiazepine for 4 weeks, followed by a 2-to 4-week taper. Diazepam may also enhance the effect of psychological treatment in patients who are initially unresponsive to this treatment alone (31). However, clinicians must balance the benefits of benzodiazepines with the risk for dependence and cognitive impairment or delirium.
Azapirones, such as buspirone, are alternatives to benzodiazepines. Two systematic reviews have shown that azapirones are superior to placebo and equivalent to benzodiazepines in the treatment of GAD (31, 42). However, sedation and dizziness are common side effects of these drugs and can occur more frequently than in patients given benzodiazepines. Azapirones can also take weeks to achieve their effect. If antidepressants, azapirones, or benzodiazepines are ineffective or poorly tolerated, alternative medication options include antipsychotics (43, 44), hydroxyzine (31), and pregabalin (31, 45, 46) . All have proven effectiveness in GAD but have significant side effects. Clinicians should consider consulting with a mental health specialist before prescribing these infrequently used drugs.
How should clinicians monitor patients?
Patients with GAD should be monitored in person or by phone every 2 to 4 weeks until stable and then every 3 to 4 months during maintenance therapy. Structured instruments may help clinicians monitor symptom severity in patients with GAD. However, there is little evidence to recommend one instrument over another and several are available. The PRIME-MD (22) and GAD-7 (Table 4) (21) can be used to guide diagnosis and monitor symptoms. Each response in the GAD-7 is assigned a value of 0, 1, 2, or 3; summary scores of 5, 10, and 15 are cut-off points for mild, moderate, and severe anxiety. There are no formal recommendations for treatment discontinuation or augmentation based on GAD-7 scores. Downloadable forms of this instrument are available in over 50 languages (www.phqscreeners.com/) (47). The new DSM-V includes a variety of additional monitoring instruments, including one that monitors symptom severity in adults with 
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Patient Information THINGS YOU SHOULD KNOW ABOUT ANXIETY
What is anxiety?
• Everyone feels worried or fearful sometimes.
• But in some people, these feelings become overwhelming, persistent, or interfere with daily life.
• Anxiety disorders include panic disorder, phobias, obsessive-compulsive disorder, and posttraumatic stress disorder.
What are the signs and symptoms?
• Extreme nervousness or worry.
• Feeling intensely panicked.
• Feeling a sense of doom or powerlessness.
• Rapid breathing (hyperventilating) and an increased heart rate.
• Sweating.
• Trembling or feeling weak or tired.
• Irresistible urges to perform purposeless acts or rituals.
• Reexperiencing the feelings of traumatic events.
How is it diagnosed?
• Your doctor will ask questions about your symptoms and conduct a careful examination.
• Laboratory tests or other tests may help identify whether your anxiety has a medical cause.
• Underlying causes for anxiety include heart disease, diabetes, thyroid problems, asthma, and drug abuse or alcohol withdrawal.
How is it treated?
• Psychotherapy (also known as cognitive behavioral therapy or psychological counseling).
• Lifestyle changes, such as avoiding alcohol and coffee and quitting smoking.
• Relaxation techniques, such as meditation or regular exercise.
• Medication, such as an antidepressant or antianxiety medication. Results of laboratory serum studies show a thyroid-stimulating hormone level of less than 0.01 µU/mL (0.01 mU/L), a free thyroxine (T4) level of 8.2 ng/dL (106 pmol/L), and a triiodothyronine (T3) level of 650 ng/dL (10 nmol/L).
For More Information
Which of the following is the most likely diagnosis?
A. Euthyroid sick syndrome B. Myxedema coma C. Subacute thyroiditis D. Thyroid storm
